Advertisement
New Zealand markets closed
  • NZX 50

    11,717.43
    -117.59 (-0.99%)
     
  • NZD/USD

    0.6084
    +0.0000 (+0.01%)
     
  • NZD/EUR

    0.5675
    -0.0003 (-0.05%)
     
  • ALL ORDS

    8,013.80
    +11.00 (+0.14%)
     
  • ASX 200

    7,767.50
    +7.90 (+0.10%)
     
  • OIL

    82.41
    +0.67 (+0.82%)
     
  • GOLD

    2,347.30
    +10.70 (+0.46%)
     
  • NASDAQ

    19,789.03
    +37.98 (+0.19%)
     
  • FTSE

    8,227.47
    +47.79 (+0.58%)
     
  • Dow Jones

    39,164.06
    +36.26 (+0.09%)
     
  • DAX

    18,334.34
    +123.79 (+0.68%)
     
  • Hang Seng

    17,718.61
    +2.14 (+0.01%)
     
  • NIKKEI 225

    39,583.08
    +241.54 (+0.61%)
     
  • NZD/JPY

    97.6180
    -0.1150 (-0.12%)
     

Argenx Surges After Its Bread-And-Butter Drug Wins Another FDA Approval

Argenx Surges After Its Bread-And-Butter Drug Wins Another FDA Approval

Argenx stock surged Monday after the FDA approved its drug, Vyvgart Hytrulo, for patients with an autoimmune condition known as CIDP.